Nanomedicine and Neurosciences : Advantages, limitations and safety aspects /
Saved in:
| Imprint: | Sharjah : Bentham Science Publishers, 2017. |
|---|---|
| Description: | 1 online resource (285 pages) |
| Language: | English |
| Series: | Frontiers in Nanomedicine ; v. 2 Frontiers in Nanomedicine ; v. 2. |
| Subject: | Medical technology. Nanotechnology. Medical innovations. HEALTH & FITNESS -- Holism. HEALTH & FITNESS -- Reference. MEDICAL -- Alternative Medicine. MEDICAL -- Atlases. MEDICAL -- Essays. MEDICAL -- Family & General Practice. MEDICAL -- Holistic Medicine. MEDICAL -- Osteopathy. Medical innovations. Medical technology. Nanotechnology. Electronic books. |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11758938 |
| LEADER | 05956cam a2200745 i 4500 | ||
|---|---|---|---|
| 001 | 11758938 | ||
| 005 | 20210426223535.8 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 170819s2017 ts ob 001 0 eng d | ||
| 003 | ICU | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d MERUC |d YDX |d OCLCQ |d N$T |d G3B |d IGB |d STF |d OCLCF |d OCLCQ |d UKAHL |d OCLCQ | ||
| 019 | |a 1001260936 | ||
| 020 | |a 1681084937 | ||
| 020 | |a 9781681084930 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1001374578 |z (OCoLC)1001260936 | ||
| 050 | 4 | |a R855.3 | |
| 072 | 7 | |a HEA |x 012000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 020000 |2 bisacsh | |
| 072 | 7 | |a MED |x 004000 |2 bisacsh | |
| 072 | 7 | |a MED |x 101000 |2 bisacsh | |
| 072 | 7 | |a MED |x 109000 |2 bisacsh | |
| 072 | 7 | |a MED |x 029000 |2 bisacsh | |
| 072 | 7 | |a MED |x 040000 |2 bisacsh | |
| 072 | 7 | |a MED |x 092000 |2 bisacsh | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Nanomedicine and Neurosciences : |b Advantages, limitations and safety aspects / |c editor, Giovanni Toasi. |
| 260 | |a Sharjah : |b Bentham Science Publishers, |c 2017. | ||
| 300 | |a 1 online resource (285 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Frontiers in Nanomedicine ; |v v. 2 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a FOREWORD ; PREFACE ; List of Contributors ; Nanomedicine and Neurodegenerative Diseases: An Introduction to Pathology and Drug Targets ; Tasnuva Sarowar1 and Andreas M. Grabrucker2,*; INTRODUCTION; CLINICAL REPRESENTATIONS; Alzheimer's Disease; Core Features of AD; Symptoms & Diagnosis of AD; Parkinson's Disease; Symptoms & Core Features of PD; Diagnosis of PD; Amytropohic Lateral Sclerosis; Core Features of ALS; Symptoms & Diagnosis of ALS; ANATOMY AND PATHOLOGY; Initiation and Progression; Alzheimer's Disease; Parkinson's Disease; Other Neurodegenerative Disorders. | |
| 505 | 8 | |a Brain Morphology, Cellular Pathology and Neurobiology of the DiseaseAlzheimer's Disease; Parkinson's Disease; Amyloid Lateral Sclerosis; GENES AND ENVIRONMENT; ; Genetics of Neurodegenerative Diseases; Candidate Genes for Alzheimer's Disease; Parkinson's Disease; Candidate Genes for Parkinson's Disease; Candidate Genes for ALS; Environmental Risk Factors; Trace Metal Alterations; Other Risk Factors; ANIMAL MODELS; Animal Models for AD; Animal Models for PD; Animal Models for ALS; Animal Models for HD; DRUG TARGETS IN NEURODEGENERATIVE DISORDERS; Drug Targets in AD; Drug Targets in PD. | |
| 505 | 8 | |a TREATMENT OF NEURODEGENERATIVE DISORDERS USING NANOMEDICINECONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGEMENT; REFERENCES; Nanoparticles Targeting Mitochondria in Neurodegenerative Diseases: Toxicity and Challenge for Nanotherapeutics ; Michal Cagalinec*; INTRODUCTION AND OVERVIEW; ALZHEIMER'S AND PARKINSON'S DISEASE; MITOCHONDRIA; MITOCHONDRIAL FUSION AND FISSION; NANOPARTICLES AND THE BRAIN; NANOPARTICLES' TOXICITY, FOCUS ON NEUROTOXICITY; NANOPARTICLES AS DRUG CARRIERS; MITOCHONDRIA AND ALZHEIMER'S DISEASE; MITOCHONDRIA AND PARKINSON'S DISEASE. | |
| 505 | 8 | |a NANOPARTICLES AND ALZHEIMER'S DISEASE TREATMENTNANOPARTICLES AND PARKINSON'S DISEASE TREATMENT; NANOPARTICLES AS DRUG DELIVERY SYSTEMS TO MITO- CHONDRIA; COULD NANOPARTICLES IMPROVE MITOCHONDRIAL FUNCTION- ING WITHOUT ENTERING MITOCHONDRIA?; FUTURE DIRECTIONS, PERSPECTIVES, LIMITATIONS; CONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; ABBREVIATIONS; REFERENCES; Neuronal Mechanisms for Nanotopography Sensing ; Ilaria Tonazzini1,2 and Marco Cecchini1,*; INTRODUCTION; Focal Adhesions and Cytoskeleton during Neuronal Cell-nanograting Interaction. | |
| 505 | 8 | |a Neuronal Differentiation Drives Nanotopography SensingNoise Tolerance in Neuronal Contact Guidance; CONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; Drug Delivery to the Brain by Liposomal Carrier Systems ; Anne Mahringer and Gert Fricker*; INTRODUCTION; LIPOSOMES; TRANSFERRIN RECEPTOR; INSULIN RECEPTOR; LDL RECEPTOR; LEPTIN RECEPTOR; RECEPTOR OF ADVANCED GLYCATION END PRODUCTS; ABSORPTIVE-MEDIATED TRANSCYTOSIS ACROSS THE BBB; ULTRASOUND AND LIPOSOMES TO OVERCOME THE BBB; CONCLUSION; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES. | |
| 500 | |a Neuronopathic LSDs: Quest for Treatments Drives Research in Nanomedicine and Nanotechnology. | ||
| 650 | 0 | |a Medical technology. |0 http://id.loc.gov/authorities/subjects/sh85083046 | |
| 650 | 0 | |a Nanotechnology. |0 http://id.loc.gov/authorities/subjects/sh91001490 | |
| 650 | 0 | |a Medical innovations. |0 http://id.loc.gov/authorities/subjects/sh85082946 | |
| 650 | 7 | |a HEALTH & FITNESS |x Holism. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Reference. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Alternative Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Atlases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Essays. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Family & General Practice. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Holistic Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Osteopathy. |2 bisacsh | |
| 650 | 7 | |a Medical innovations. |2 fast |0 (OCoLC)fst01014181 | |
| 650 | 7 | |a Medical technology. |2 fast |0 (OCoLC)fst01014742 | |
| 650 | 7 | |a Nanotechnology. |2 fast |0 (OCoLC)fst01032639 | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Tosi, Giovanni. | |
| 776 | 0 | 8 | |i Print version: |a Tosi, Giovanni. |t Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects. |d Sharjah : Bentham Science Publishers, ©2017 |z 9781681084947 |
| 830 | 0 | |a Frontiers in Nanomedicine ; |v v. 2. | |
| 856 | 4 | 0 | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1580981 |y eBooks on EBSCOhost |
| 903 | |a HeVa | ||
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i f20b726c-1145-5169-b79b-4c3d03b35916 |s c5a14989-16b3-5272-a741-bbb9cb28ee32 |
| 928 | |t Library of Congress classification |a R855.3 |l Online |c UC-FullText |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1580981 |z eBooks on EBSCOhost |g ebooks |i 12455935 | ||